Shares Outstanding Shares Outstanding n/a Close	161.82M
Shares Change (YoY) Shares Change (YoY) n/a Close	0.67%
Shares Change (QoQ) Shares Change (QoQ) n/a Close	0%
Owned by Institutions (%) Owned by Institutions (%) n/a Close	99.99%
Shares Floating Shares Floating n/a Close	n/a
Failed to Deliver (FTD) Shares Failed to Deliver (FTD) Shares n/a Close	3,700
FTD / Avg. Volume FTD / Avg. Volume n/a Close	0.11%

Short Selling Information

The latest short interest is 8.47M, so 5.23% of the outstanding shares have been sold short.

Short Interest Short Interest n/a Close	8.47M
Short % of Shares Out Short % of Shares Out n/a Close	5.23%
Short % of Float Short % of Float n/a Close	7.95%
Short Ratio (days to cover) Short Ratio (days to cover) n/a Close	3.59

Valuation Ratios

The PE ratio is 800.84 and the forward PE ratio is 1.64. Ironwood Pharmaceuticals's PEG ratio is -8.

PE Ratio PE Ratio n/a Close	800.84
Forward PE Forward PE n/a Close	1.64
PS Ratio PS Ratio n/a Close	2.01
Forward PS Forward PS n/a Close	0.4
PB Ratio PB Ratio n/a Close	-2.34
P/FCF Ratio P/FCF Ratio n/a Close	6.82
PEG Ratio PEG Ratio n/a Close	-8

Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Ironwood Pharmaceuticals.

EV / Sales EV / Sales n/a Close	n/a
EV / EBITDA EV / EBITDA n/a Close	n/a
EV / EBIT EV / EBIT n/a Close	n/a
EV / FCF EV / FCF n/a Close	n/a

Financial Position

The company has a current ratio of 4.69, with a Debt / Equity ratio of -1.99.

Current Ratio Current Ratio n/a Close	4.69
Quick Ratio Quick Ratio n/a Close	4.69
Debt / Equity Debt / Equity n/a Close	-1.99
Debt / EBITDA Debt / EBITDA n/a Close	5.98
Debt / FCF Debt / FCF n/a Close	5.8
Interest Coverage Interest Coverage n/a Close	2.82

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

Return on Equity Return on Equity n/a Close	n/a
Return on Assets Return on Assets n/a Close	n/a
Return on Invested Capital Return on Invested Capital n/a Close	n/a
Revenue Per Employee Revenue Per Employee n/a Close	$1,388,972.33
Profits Per Employee Profits Per Employee n/a Close	$3,478.26
Employee Count Employee Count n/a Close	253
Asset Turnover Asset Turnover n/a Close	1
Inventory Turnover Inventory Turnover n/a Close	n/a

Taxes

Income Tax Income Tax n/a Close	64.32M
Effective Tax Rate Effective Tax Rate n/a Close	98.65%

Stock Price Statistics

The stock price has increased by -90.55% in the last 52 weeks. The beta is 0.23, so Ironwood Pharmaceuticals's price volatility has been higher than the market average.

Beta Beta n/a Close	0.23
52-Week Price Change 52-Week Price Change n/a Close	-90.55%
50-Day Moving Average 50-Day Moving Average n/a Close	0.85
200-Day Moving Average 200-Day Moving Average n/a Close	2.86
Relative Strength Index (RSI) Relative Strength Index (RSI) n/a Close	40.85
Average Volume (20 Days) Average Volume (20 Days) n/a Close	3,293,558

Income Statement

In the last 12 months, Ironwood Pharmaceuticals had revenue of 351.41M and earned 880K in profits. Earnings per share was 0.01.

Revenue Revenue n/a Close	351.41M
Gross Profit Gross Profit n/a Close	351.41M
Operating Income Operating Income n/a Close	93.12M
Net Income Net Income n/a Close	880K
EBITDA EBITDA n/a Close	100.24M
EBIT EBIT n/a Close	98.23M
Earnings Per Share (EPS) Earnings Per Share (EPS) n/a Close	0.01

Full Income Statement

Balance Sheet

The company has 88.56M in cash and 599.48M in debt, giving a net cash position of -510.92M.

Cash & Cash Equivalents Cash & Cash Equivalents n/a Close	88.56M
Total Debt Total Debt n/a Close	599.48M
Net Cash Net Cash n/a Close	-510.92M
Retained Earnings Retained Earnings n/a Close	-1.7B
Total Assets Total Assets n/a Close	327.21M
Working Capital Working Capital n/a Close	112.48M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 103.55M and capital expenditures -142K, giving a free cash flow of 103.41M.

Operating Cash Flow Operating Cash Flow n/a Close	103.55M
Capital Expenditures Capital Expenditures n/a Close	-142K
Free Cash Flow Free Cash Flow n/a Close	103.41M
FCF Per Share FCF Per Share n/a Close	0.65

Full Cash Flow Statement

Margins

Gross margin is 100%, with operating and profit margins of 26.5% and 0.25%.

Gross Margin Gross Margin n/a Close	100%
Operating Margin Operating Margin n/a Close	26.5%
Pretax Margin Pretax Margin n/a Close	18.55%
Profit Margin Profit Margin n/a Close	0.25%
EBITDA Margin EBITDA Margin n/a Close	28.53%
EBIT Margin EBIT Margin n/a Close	26.5%
FCF Margin FCF Margin n/a Close	29.43%

Dividends & Yields

IRWD does not appear to pay any dividends at this time.

Dividend Per Share Dividend Per Share n/a Close	n/a
Dividend Yield Dividend Yield n/a Close	n/a
Dividend Growth (YoY) Dividend Growth (YoY) n/a Close	n/a
Payout Ratio Payout Ratio n/a Close	n/a
Earnings Yield Earnings Yield n/a Close	n/a
FCF Yield FCF Yield n/a Close	n/a

Dividend Details

Analyst Forecast

The average price target for IRWD is $1, which is 66.7% higher than the current price. The consensus rating is "Hold".

Price Target Price Target n/a Close	$1
Price Target Difference Price Target Difference n/a Close	66.7%
Analyst Consensus Analyst Consensus n/a Close	Hold
Analyst Count Analyst Count n/a Close	5

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value Lynch Fair Value n/a Close	$0.05
Lynch Upside Lynch Upside n/a Close	-91.67%
Graham Number Graham Number n/a Close	n/a
Graham Upside Graham Upside n/a Close	n/a

Stock Splits

The last stock split was on Apr 2, 2019. It was a forward split with a ratio of 597:500.

Last Split Date Last Split Date n/a Close	Apr 2, 2019
Split Type Split Type n/a Close	forward
Split Ratio Split Ratio n/a Close	597:500

Scores

Altman Z-Score Altman Z-Score n/a Close	-5.37
Piotroski F-Score Piotroski F-Score n/a Close	5